142 related articles for article (PubMed ID: 29654976)
1. Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone.
Simithy J; Fuanta NR; Hobrath JV; Kochanowska-Karamyan A; Hamann MT; Goodwin DC; Calderón AI
Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):731-739. PubMed ID: 29654976
[TBL] [Abstract][Full Text] [Related]
2. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
Simithy J; Gill G; Wang Y; Goodwin DC; Calderón AI
Anal Chem; 2015 Feb; 87(4):2129-36. PubMed ID: 25629762
[TBL] [Abstract][Full Text] [Related]
3. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
[TBL] [Abstract][Full Text] [Related]
4. The mode of action of recombinant Mycobacterium tuberculosis shikimate kinase: kinetics and thermodynamics analyses.
Rosado LA; Vasconcelos IB; Palma MS; Frappier V; Najmanovich RJ; Santos DS; Basso LA
PLoS One; 2013; 8(5):e61918. PubMed ID: 23671579
[TBL] [Abstract][Full Text] [Related]
5. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue.
Gan J; Gu Y; Li Y; Yan H; Ji X
Biochemistry; 2006 Jul; 45(28):8539-45. PubMed ID: 16834327
[TBL] [Abstract][Full Text] [Related]
7. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
8. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
[TBL] [Abstract][Full Text] [Related]
9. Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids.
Simithy J; Fuanta NR; Alturki M; Hobrath JV; Wahba AE; Pina I; Rath J; Hamann MT; DeRuiter J; Goodwin DC; Calderón AI
Biochemistry; 2018 Aug; 57(32):4923-4933. PubMed ID: 30063132
[TBL] [Abstract][Full Text] [Related]
10. Shikimate kinase, a protein target for drug design.
Coracini JD; de Azevedo WF
Curr Med Chem; 2014; 21(5):592-604. PubMed ID: 24164195
[TBL] [Abstract][Full Text] [Related]
11. Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages.
Chen D; Ma S; He L; Yuan P; She Z; Lu Y
Tuberculosis (Edinb); 2017 Mar; 103():37-43. PubMed ID: 28237032
[TBL] [Abstract][Full Text] [Related]
12. Development of an ultrafiltration-liquid chromatography/mass spectrometry (UF-LC/MS) based ligand-binding assay and an LC/MS based functional assay for Mycobacterium tuberculosis shikimate kinase.
Mulabagal V; Calderón AI
Anal Chem; 2010 May; 82(9):3616-21. PubMed ID: 20394394
[TBL] [Abstract][Full Text] [Related]
13. Interaction of shikimic acid with shikimate kinase.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; de Azevedo WF; Santos DS
Biochem Biophys Res Commun; 2004 Dec; 325(1):10-7. PubMed ID: 15522194
[TBL] [Abstract][Full Text] [Related]
14. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
[TBL] [Abstract][Full Text] [Related]
15. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
17. Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity.
Kwak CH; Jin L; Han JH; Han CW; Kim E; Cho M; Chung TW; Bae SJ; Jang SB; Ha KT
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825675
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis.
Gu Y; Reshetnikova L; Li Y; Wu Y; Yan H; Singh S; Ji X
J Mol Biol; 2002 Jun; 319(3):779-89. PubMed ID: 12054870
[TBL] [Abstract][Full Text] [Related]
19. A multifaceted approach to identify non-specific enzyme inhibition: Application to Mycobacterium tuberculosis shikimate kinase.
Alturki MS; Fuanta NR; Jarrard MA; Hobrath JV; Goodwin DC; Rants'o TA; Calderón AI
Bioorg Med Chem Lett; 2018 Feb; 28(4):802-808. PubMed ID: 29366649
[TBL] [Abstract][Full Text] [Related]
20. LC-MS metabolite fingerprinting and MtSK-based screening of an endophyte Bartalinia pondoensis Marinc of Citrus aurantum L.
Zaher AM; Makboul MA; Moharram AM; Calderón AI
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 970():18-23. PubMed ID: 25222744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
